Publication dates

All regions

Colorectal Cancer Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Cancer, Medical Equipment, Melanoma, more »


 
1-20 of about 8 700 reports for Colorectal Cancer

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... cancer ctc detection kit - product status 12colorectal cancer ctc detection kit - product description 12diagnostic test - ovarian cancer - product status 13diagnostic test - ovarian cancer ...

Ascenion GmbH - Product Pipeline Analysis, 2014 Update

Ascenion GmbH - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... Acad ii - product description 21biomarker assay - inflammatory disease - product status 22biomarker assay - inflammatory disease - product description 22biomarker test - colorectal cancer ...

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... Biomarker test - colorectal cancer - product status 19biomarker test - colorectal cancer - product description 19cancer diagnostic test - product status 20cancer diagnostic test - product ...

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

... Mutation status that present the best opportunities for crc therapeutics in each of the markets covered. Epicast report: colorectal cancer - epidemiology forecast to 2023 1 table of contents2 ...

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Such as fatigue and appetite loss, anemia, colorectal cancer, liver cancer, rheumatoid arthritis and hepatitis c, among others. The company has collaboration with multinational pharmaceutical or biotech companies ...

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Of parkinson's disease. The company's att-11t is a therapeutic compound used in the treatment of metastatic solid tumors such as colorectal cancer, lung cancer and ovarian cancer. It markets products through ...

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And commercializes genomic-based clinical laboratory tests. It develops diagnostic tests such as, colonsentry and sentinelgx. Genenews colonsentry is a blood test for colorectal cancer and sentinelgx is used in whole ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Depletion and recovery technology for serum or plasma and other biological fluids. The company offers products for the treatment of colorectal cancer and prostate cancer. It holds for vascular permeability ...

MOLOGEN AG (Symbol:MGN) SWOT Analysis, Strategy, Revenues and Profits

MOLOGEN AG (Symbol:MGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Products for oncology, which include mgn1703 for the treatment of advanced colorectal cancer, mgn1601 for the treatment of treat advanced kidney cancer and mgn1404 for malignant melanoma; and products ...

Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And cxcolorectal. The company's cxcolorectal is a prognostic gene signature for patients diagnosed with stage ii and stage iii colorectal cancer. Its cxbladder is a non-invasive laboratory test for the detection ...

About 1 600 reports for Colorectal Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in China

  • November 2014
    9 pages
  • Colorectal Canc  

    Cancer  

  • China  

View report >

3 Companies for Colorectal Cancer

Read our Company Profiles

Eli Lilly and Co.

United States

Johnson and Johnson

United States

Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.